Vertex Pharmaceuticals: buy signal confirmed, sector in acceleration
Vertex Pharmaceuticals · week 1 of a buy signal, already up 8.79%. Technical analysis on a US stock with a confirmed trade setup: Health Care sector running, confirmation week closed bullish — model suggests adding.
Vertiv Holdings: sell signal holds but double bottom demands attention
Vertiv Holdings sell signal enters week 4: -8.7% with 94% sell volume, while a double bottom pattern in the 295 area on the daily chart raises caution. Trade setup at elevated risk per our model. Weekly technical analysis.
Valero Energy: 10% rebound off double bottom, trade still running
Valero Energy week 24 buy trade — a 10% weekly rebound with 95% buy volume confirms technical strength after the double bottom. Weekly technical analysis shows the stock pressing against a heavily tested resistance in the 260 area, a key level to monitor for the trade setup.
Vanguard Dividend Appreciation ETF: all 3 targets hit, residual capital still running
VIG weekly trade setup — week 11 of a buy signal, +5.9% performance, all 3 model targets hit. The stop now trails the Inversion Point; residual capital runs until a sell signal or the stop is touched.
Vanguard Information Technology ETF — week 10, all 3 model targets hit
Vanguard Information Technology ETF — week 10 of a buy setup, trade setup with +13% performance since entry. All 3 statistical targets of our most advanced model were hit within 5 weeks; breakeven stop in place. Statistical coverage ends at this milestone.
Vanguard FTSE Europe ETF: all 3 windows closed, residual capital runs with trailing stop
Week 11 of the buy signal on VGK: all 3 model time windows have passed and the residual capital continues with a trailing stop on the Inversion Point. Technical analysis shows a trade setup in attenuation — structure intact but MACD in bearish cross and stock performance flat near highs. t